CLOSING BELL
Europe
  • 🇬🇧 FTSE 100-0.40%
  • 🇩🇪 DAX+0.61%
  • 🇫🇷 CAC 40-0.13%

Europe closed split: German equities gained 0.6% while London finished at 10,789.93. Treating "European exposure" as one trade means missing the divergence inside it.

FRMIFRMI
Regular session
$6.92
-9.01%open $7.60

The reaction to Fermi's Q2 earnings is intensifying: a 9% slide to $6.92 wipes out the resistance test traders were watching hours ago. Next level to hold is the $6.90 area.

COHRCoherent
Regular session
$340.00
-4.40%open $355.64

Down 4.4% to $340 in the session right after Coherent's Q4 2026 earnings beat, so buyers are treating good numbers as a chance to take profits in an AI-optics leader. Keep an eye on whether $340 holds.

Stock picks

Hold Intel And Strictly Follow These Binary Catalysts

Intel has staged one of the most dramatic stock revivals in recent memory, but two unresolved catalysts will either confirm the turnaround as real or expose this year’s triple-digit rally as a trade that ran far ahead of the fundamentals.

CBRSCBRS
Regular session
$225.85
-13.82%open $262.06

The selling is picking up speed: a 13.82% drop to $225.85 in the session after Cerebras' Q2 2026 earnings miss. Anyone who bought the first dip near $233 is already underwater, so keep an eye on where buyers step back in.

CSCOCisco Systems
Regular session
$111.92
-9.65%open $123.88

Down 9.65% to $111.92, and this is a mega-cap that rarely moves this hard in a single session. The selling follows last night's Q4 earnings beat, so the market is pricing something other than the headline numbers.

CBRSCBRS
Regular session
$232.98
-11.10%open $262.06

An 11% slide to $232.98 puts the first real dent in Cerebras since its Q2 2026 earnings report missed expectations.

FRMIFRMI
Regular session
$7.14
-6.05%open $7.60

Down 6.05% to $7.14 in the first session after Fermi's Q2 2026 results hit EDGAR, and the slide takes the stock back below the $7.74 resistance traders were watching. Next test is whether it holds here or slips further.

Stock picks

Great Company, Full Price: What Arm's Numbers Say About the Next 12 Months

Arm just posted its third straight year of 20-plus percent revenue growth with the AI era’s dominant compute platform, yet the stock sits 33% below its recent peak and Wall Street’s upside calls look surprisingly timid given what the AGI CPU pipeline could actually deliver.